Literature DB >> 22454959

Plasma concentrations of methimazole, a metabolite of carbimazole, in hyperthyroid patients.

G G Skellern1, J B Stenlake, W D Williams, D G McLarty.   

Abstract

1 Carbimazole was administered to nine hyperthyroid patients, and blood samples were taken at various time intervals for analysis of carbimazole, and its metabolite methimazole.2 A technique was developed for the measurement of methimazole in serum using a High-Pressure Liquid Chromatograph, which could detect nanogram quantities of this metabolite.3 After a single oral dose, the patients' blood levels appeared to fall into two groups, either those with a maximum concentration of methimazole between 30 and 60 min, or those whose maximum was 2 to 3 hours.4 The results would suggest that there could be a correlation between the high level of methimazole in serum and the high thyroxine concentration found in some patients.

Entities:  

Year:  1974        PMID: 22454959      PMCID: PMC1402560          DOI: 10.1111/j.1365-2125.1974.tb00248.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  11 in total

1.  DETERMINATION AND IDENTIFICATION OF AMPHETAMINE IN URINE.

Authors:  A H BECKETT; M ROWLAND
Journal:  J Pharm Pharmacol       Date:  1965-01       Impact factor: 3.765

2.  A fluorimetric assay for minute amounts of some thiohydantoins.

Authors:  M E AUERBACH; E ANGELL
Journal:  J Pharm Pharmacol       Date:  1958-12       Impact factor: 3.765

3.  EFFECT OF THYROXINE ON THYROID UPTAKE OF THIOUREA-S35.

Authors:  H JUAREZ PENALVA; M L MITCHELL
Journal:  Proc Soc Exp Biol Med       Date:  1964-01

4.  The acclumulation of 35 S-antithyroid drugs by the thyroid gland.

Authors:  B Marchant; W D Alexander; J H Lazarus; J Lees; D H Clark
Journal:  J Clin Endocrinol Metab       Date:  1972-05       Impact factor: 5.958

5.  The thyroid accumulation, oxidation and metabolic fate of 35 S-methimazole in the rat.

Authors:  B Marchant; W D Alexander
Journal:  Endocrinology       Date:  1972-09       Impact factor: 4.736

6.  Methimazole: its absorption and excretion in man and tissue distribution in rats.

Authors:  J A Pittman; R J Beschi; T C Smitherman
Journal:  J Clin Endocrinol Metab       Date:  1971-08       Impact factor: 5.958

7.  Methimazole: absorption, metabolism and excretion in the albino rat.

Authors:  D S Sitar; D P Thornhill
Journal:  J Pharmacol Exp Ther       Date:  1973-02       Impact factor: 4.030

8.  Generic inequivalence--clinical observations.

Authors:  L F Prescott; J Nimmo
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1971

9.  Effect of thyroid hormone on the substrate interaction with P-450 in the oxidation of drugs by liver microsomes.

Authors:  R Kato; A Takanaka; A Takahashi
Journal:  J Biochem       Date:  1970-11       Impact factor: 3.387

10.  Development and comparison of thin-layer chromatographic and gas-liquid chromatographic methods for measurement of methimazole in rat urine.

Authors:  J B Stenlake; W D Williams; G G Skellern
Journal:  J Chromatogr       Date:  1970-12
View more
  9 in total

1.  Comparative In Vitro Effects and In Vivo Kinetics of Antithyroid Drugs.

Authors:  A Melander; B Hallengren; S Rosendal-Helgesen; A K Sjöberg; E Wählin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1980-04       Impact factor: 2.953

Review 2.  Influence of thyroid dysfunction on drug pharmacokinetics.

Authors:  G M Shenfield
Journal:  Clin Pharmacokinet       Date:  1981 Jul-Aug       Impact factor: 6.447

Review 3.  Pharmacokinetics of antithyroid drugs.

Authors:  G Benker; D Reinwein
Journal:  Klin Wochenschr       Date:  1982-06-01

4.  Influence of hyperthyroidism on the kinetics of methimazole, propranolol, metoprolol and atenolol.

Authors:  B Hallengren; O R Nilsson; B E Karlberg; A Melander; L Tegler; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Pharmacokinetic properties and bioavailability of methimazole.

Authors:  R Jansson; B Lindström; P A Dahlberg
Journal:  Clin Pharmacokinet       Date:  1985 Sep-Oct       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of antithyroid drugs.

Authors:  J P Kampmann; J M Hansen
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Pharmacokinetics of methimazole in humans.

Authors:  J H Hengstmann; H Hohn
Journal:  Klin Wochenschr       Date:  1985-12-02

8.  Excretion of methimazole in human milk.

Authors:  K Johansen; A N Andersen; J P Kampmann; J M Mølholm Hansen; H B Mortensen
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

9.  A patient-specific treatment model for Graves' hyperthyroidism.

Authors:  Balamurugan Pandiyan; Stephen J Merrill; Flavia Di Bari; Alessandro Antonelli; Salvatore Benvenga
Journal:  Theor Biol Med Model       Date:  2018-01-09       Impact factor: 2.432

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.